| Overview |
| bsm-61852r-fitc-100ul |
| CD39L4 Recombinant Antibody, FITC Conjugated |
| WB, IF |
| Human, Mouse, Rat |
| Specifications |
| FITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human ENTPD5 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 957 |
| O75356 |
| Cytoplasm, Cell membrane |
| CD39L4; Entpd5; mNTPase; NTPDase 5; PCPH; UDPase ENTPD5. |
| In the lumen of the endoplasmic reticulum, hydrolyzes UDP that acts as an end-product feedback inhibitor of the UDP-Glc:glycoprotein glucosyltransferases. UMP can be transported back by an UDP-sugar antiporter to the cytosol where it is consumed to regenerate UDP-glucose. Therefore, it positively regulates protein reglucosylation by clearing UDP from the ER lumen and by promoting the regeneration of UDP-glucose. Protein reglucosylation is essential to proper glycoprotein folding and quality control in the ER. |
| Application Dilution |
| WB |
1:300-5000 |
| IF |
|
Powered by Bioz